NEW YORK (GenomeWeb) – Spanish diagnostics company Imegen has been acquired by private equity investors for €10 million ($10.8 million), according to a European news report which the company has confirmed.

Q-Growth Fund and Biolty bought out 41 of the 42 shareholders in the Valencia, Spain-based firm. The investors are also Spanish firms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.